Reps. Henry Waxman (D-Calif.) and Bart Stupak (D-Mich.) are again pressing Schering-Plough Corp. and Merck & Co. for huge amounts of information about clinical trials related to Vytorin. They’re also continuing to question other professional societies about relationships with industry (RWI). It’s tough.

I’m glad we came through our encounters with these committees early and swimmingly, but we are not relaxing our efforts at increasing RWI transparency and high integrity in avoiding and disclosing. In fact, we are about to post all conflicts and RWI issues of individual ACC Board Trustees and State Chapter Governors on our Web site (by the time of the Annual Scientific Session in March), along with our existing full posting of all grants and industry funding, journal advertising, etc., to the College itself. This will be much appreciated by Congress, Institute of Medicine and others.  

*** Image from Flickr (macwagen). ***

< Back to Listings